Emetine Regulates the Alternative Splicing of Bcl-x through a Protein Phosphatase 1-Dependent Mechanism
- 26 December 2007
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 14 (12), 1386-1392
- https://doi.org/10.1016/j.chembiol.2007.11.004
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- siRNA‐MEDIATED BCL‐2 AND BCL‐XL GENE SILENCING SENSITIZES HUMAN HEPATOBLASTOMA CELLS TO CHEMOTHERAPEUTIC DRUGSClinical and Experimental Pharmacology and Physiology, 2007
- Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent diseaseGynecologic Oncology, 2005
- Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPACell Research, 2004
- De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma CellsJournal of Biological Chemistry, 2002
- Bcl-XL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapyInternational Journal of Cancer, 2002
- Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistanceCell Death & Differentiation, 2000
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- Specific Inhibition of Translocation by Tubulosine in Eukaryotic PolysomesEuropean Journal of Biochemistry, 1976
- Inhibitors of Ribosome FunctionsAnnual Review of Microbiology, 1971
- Increased Lifespan of Leukemic Mice Treated with Drugs Related to (–)-EmetineChemotherapy, 1971